Curis
CRIS
#10292
Rank
S$14.31 M
Marketcap
S$1.11
Share price
-2.90%
Change (1 day)
-76.82%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -S$42.89 Million

According to Curis's latest financial reports the company's current earnings are S$11.65 Million. In 2024 the company made an earning of -S$54.3 Million, an increase over its 2023 earnings that were of -S$57.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$42.89 Million-21.02%
2024 -S$54.3 Million-5.77%
2023 -S$57.63 Million-13.1%
2022 -S$66.32 Million27.52%
2021 -S$52.01 Million65.09%
2020 -S$31.5 Million-9.1%
2019 -S$34.66 Million-4.73%
2018 -S$36.37 Million-41.95%
2017 -S$62.65 Million-14.37%
2016 -S$73.17 Million3.55%
2015 -S$70.66 Million271.52%
2014 -S$19.02 Million76.64%
2013 -S$10.77 Million
2011 -S$9.15 Million27.76%
2010 -S$7.16 Million-43.87%
2009 -S$12.76 Million-23.44%
2008 -S$16.66 Million56.66%
2007 -S$10.64 Million-16.71%
2006 -S$12.77 Million-36.92%
2005 -S$20.24 Million156.25%
2004 -S$7.9 Million-37.24%
2003 -S$12.59 Million-93.34%
2002 -S$0.19 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.04 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.19 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$78.56 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.10 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.44 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.20 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA